The scope of this study entails the worldwide market for thawing systems. The report covers the entire market for thawing systems, which incorporates four sample types: blood, embryo and ovum, semen, and stem cells. Based on the end user, thawing systems are divided into blood bank and transfusion centers, hospitals and diagnostic centers, biotechnology and pharma companies, and research and academic institutes.
By geographical region, the market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. For market estimates, data has been provided for the year 2021 as the base year, with forecasts for 2022-2027. Estimated values are based on device manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Report Includes
- 25 tables
- An overview of the global markets for thawing systems
- Estimation of market size and analyses of global market trends, with data from 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Coverage of history and principles of cryopreservation, and discussion on impact of cryopreservation and freeze-thawing on therapeutic properties
- Assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the thawing systems market
- Discussion on the implications of thawing systems in the context of the current size and growth of the medical device market, and description of important technologies that supports thawing devices
- Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
- Profiles of the key companies in the thawing systems market, including BioLife Solutions Inc., Cardinal Health, Sartorius, Cytiva Life Sciences, Boekel Scientific, FreMon Scientific Inc., and Helmer Scientific Inc.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Intended Audience
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 Custom Research
1.10 Related Research Reports
Chapter 2 Summary and Highlights
2.1 Market Size and Evolution
Chapter 3 Market Overview
3.1 History and Principles of Cryopreservation
3.1.1 Principles of Cryopreservation
3.2 Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties
3.2.1 Hematopoietic Stem and Progenitor Cells (Hspcs)
3.2.2 Mesenchymal Stromal/Stem Cells (Mscs)
3.2.3 Other Common Cellular Therapeutics
3.3 Guide to Cell Thawing
3.3.1 Controlled Cooling for Stable Thawing
3.3.2 Ice Formation During Cooling
3.3.3 Post-Thaw Toxicity
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.2 Market Restraints
3.4.3 Opportunity
3.5 Impact of Covid-19 on the Thawing System Market
Chapter 4 Global Market Breakdown
4.1 Overview
4.2 Global Market of Thawing Systems, by Sample Type
4.2.1 Blood
4.2.2 Stem Cell
4.2.3 Embryo and Ovum
4.2.4 Semen
4.3 Global Market of Thawing Systems, by End-user
4.3.1 Biotechnology and Pharma Companies
4.3.2 Blood Banks and Transfusion Centers
4.3.3 Hospitals and Diagnostic Centers
4.3.4 Academic and Research Institutes
Chapter 5 Market Breakdown, by Region
5.1 Introduction
5.2 North America
5.3 Europe
5.4 Asia-Pacific
5.5 Rest of the World
Chapter 6 Industry Trends and Emerging Technologies
6.1 Competitive Landscape
6.2 Emerging Technologies
Chapter 7 Company Profiles
- Antrad Medical Ab
- Biolife Solutions Inc.
- Boekel Scientific.
- Cardinal Health
- Cytiva Life Sciences
- Fremon Scientific Inc.
- Helmer Scientific Inc.
- Kw Scientific Devices Srl
- Sarstedt AG & Co.
- Sartorius
- Stericox India Private Limited
List of Tables
Summary Table: Global Market for Thawing Systems, by Sample Type, Through 2027
Table 1: Commonly Used Cryoprotective Agents and Their Uses
Table 2: Cryochain Process Step Wise
Table 3: Global Cancer Statistics, 2020
Table 4: Global Market for Thawing Systems, Through 2027
Table 5: Global Market for Thawing Systems, by Sample Type, Through 2027
Table 6: Global Market for Blood Thawing Systems, by Region, Through 2027
Table 7: Global Market for Stem Cell Thawing Systems, by Region, Through 2027
Table 8: Global Market for Embryo and Ovum Thawing Systems, by Region, Through 2027
Table 9: Global Market for Semen Thawing Systems, by Region, Through 2027
Table 10: Global Market for Thawing Systems, by End User, Through 2027
Table 11: Global Market for Biotechnology and Pharma Companies in Thawing Systems, by Region, Through 2027
Table 12: Global Market for Blood Banks and Transfusion Centers in Thawing Systems, by Region, Through 2027
Table 13: Global Market for Hospitals and Diagnostic Centers in Thawing Systems, by Region, Through 2027
Table 14: Global Market for Academic and Research Institutes in Thawing Systems, by Region, Through 2027
Table 15: Global Market for Thawing Systems, by Region, Through 2027
Table 16: North American Market for Thawing Systems, by Sample Type, Through 2027
Table 17: North American Market for Thawing Systems, by End User, Through 2027
Table 18: European Market for Thawing Systems, by Sample Type, Through 2027
Table 19: European Market for Thawing Systems, by End User, Through 2027
Table 20: Asia-Pacific Market for Thawing Systems, by Sample Type, Through 2027
Table 21: Asia-Pacific Market for Thawing Systems, by End User, Through 2027
Table 22: Rest of the World Market for Thawing Systems, by Sample Type, Through 2027
Table 23: Rest of the World Market for Thawing Systems, by End User, Through 2027
Table 24: Competitive Analysis: Thawing Systems Market, 2021
List of Figures
Summary Figure A: Global Market Shares of Thawing Systems, by Sample Type, 2021
Summary Figure B: Growth Rate of North America, Europe, and Asia-Pacific Markets for Thawing Systems
Figure 1: Structure of Four Common Permeating Cryoprotectants
Figure 2: Impact of Cryopreservation and Freeze-Thawing on Clinical Cell Therapies
Figure 3: A Typical Cryochain
Figure 4: Schematic of Cells During Cooling, Thawing, and After Thaw
Figure 5: Global Market Shares of Thawing Systems, by Sample Type, 2021
Figure 6: Estimated Whole Blood Donations, by Region, 2017
Figure 7: Global Market for Blood Thawing Systems, 2019-2027
Figure 8: Global Market for Blood Thawing Systems, by Region, 2019-2027
Figure 9: Global Market for Stem Cell Thawing Systems, 2019-2027
Figure 10: Global Market for Stem Cell Thawing Systems, by Region, 2019-2027
Figure 11: Number of IVF Cycles Over Time, by Fresh and Frozen Embryos in the U.K., 1991-2019
Figure 12: Global Market for Embryo and Ovum Thawing Systems, 2019-2027
Figure 13: Global Market for Embryo and Ovum Thawing Systems, by Region, 2019-2027
Figure 14: Global Market for Semen Thawing Systems, 2019-2027
Figure 15: Global Market for Semen Thawing Systems, by Region, 2019-2027
Figure 16: Global Market Shares of Thawing Systems, by End User, 2021
Figure 17: Private Investment, Cell and Gene Therapy, 2014-2021
Figure 18: Global Market for Biotechnology and Pharma Companies in Thawing Systems, 2019-2027
Figure 19: Global Market for Biotechnology and Pharma Companies in Thawing Systems, by Region, 2019-2027
Figure 20: Global Market for Blood Banks and Transfusion Centers in Thawing Systems, 2019-2027
Figure 21: Global Market for Blood Banks and Transfusion Centers in Thawing Systems, by Region, 2019-2027
Figure 22: Global Market for Hospitals and Diagnostic Centers in Thawing Systems, 2019-2027
Figure 23: Global Market for Hospitals and Diagnostic Centers in Thawing Systems, by Region, 2019-2027
Figure 24: Global Market for Academic and Research Institutes in Thawing Systems, 2019-2027
Figure 25: Global Market for Academic and Research Institutes in Thawing Systems, by Region, 2019-2027
Figure 26: Global Market for Thawing Systems, by Region, 2019-2027
Figure 27: Global Market Shares of Thawing Systems, by Region, 2021
Figure 28: BioLife Solutions Inc.: Annual Revenue, 2019-2021
Figure 29: BioLife Solutions Inc.: Revenue Shares, by Products and Services, 2021
Figure 30: Cardinal Health: Annual Revenue, 2019-2021
Figure 31: Cardinal Health: Revenue Share, by Business Segment, 2021
Figure 32: Cardinal Health: Revenue Share, by Region, 2021
Figure 33: Danaher Life Science Segment (including Cytiva): Annual Revenue, 2019-2021
Figure 34: Danaher Life Sciences Segment (Including Cytiva): Market Share, by Region, 2021
Figure 35: Sartorius: Annual Revenue, 2019-2021
Figure 36: Sartorius: Market Share, by Region, 2021
Figure 37: Sartorius: Market Share, by Business Segment, 2021
Executive Summary
Organelles, cells, tissues, and other biological constructions can all be preserved by a method called cryopreservation, where they are cooled to extremely low temperatures. The reactions of living organisms to ice formation are both theoretically fascinating and practically useful. For the best cryopreservation and recovery, a controlled rate of freezing and quick thawing is required. Transient warming episodes during transfer and storage must be minimized since they affect viability and recovery. Compared to passive thawing, active thawing increases cell viability and recovery.
Transfusions of blood are a crucial therapeutic strategy. In an emergency, we might all use blood, and some of us require transfusions frequently. A transfusion is performed to provide the patient with the blood component(s) that will improve their physiological condition. A single gift of whole blood can be used to produce several different blood components. Red blood cells and plasma components can typically be separated in blood banks. Others can manufacture ingredients like cryoprecipitate and platelet concentrates. Blood is drawn from the patient at body temperature or 37 °C. However, it must be chilled to below +10 °C for transportation and kept at refrigeration temperatures of roughly +4 °C until use to preserve its essential qualities. In that step, blood-thawing devices are required.
Before being used in IVF, a previously frozen sperm sample is recovered and processed using a sperm thaw method. The patient's sperm sample is located. The vial is taken out of liquid nitrogen storage, and its accuracy is checked against the patient's records. The sample is subsequently warmed in thawing equipment or a water bath, and the concentration, motility, and progression of the sperm are assessed. It's a good idea to have a backup plan in case something goes wrong.
Using automation and slower thawing rates, dry thawing systems improve consistency between thawing operations while reducing cell cryoprotectant degradation.
Companies Mentioned
- Antrad Medical Ab
- Biolife Solutions Inc.
- Boekel Scientific.
- Cardinal Health
- Cytiva Life Sciences
- Fremon Scientific Inc.
- Helmer Scientific Inc.
- Kw Scientific Devices Srl
- Sarstedt AG & Co.
- Sartorius
- Stericox India Private Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 82 |
| Published | April 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 242.2 Million |
| Forecasted Market Value ( USD | $ 341.4 Million |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
